APERISYS INC has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals and biotechnology are DEMETER BIOTECH LTD, CUE BIOPHARMA INC and VOR BIOPHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Mexico | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Poznansky Mark C | 11 |
#2 | Peritt David | 7 |
#3 | Reeves Patrick | 6 |
#4 | Chen Huabiao | 5 |
#5 | Gelfand Jeffrey A | 5 |
#6 | Brauns Timothy | 5 |
#7 | Mccormack Stephen J | 5 |
#8 | Mark C Poznansky | 2 |
#9 | Stephen J Mccormack | 1 |
#10 | Timothy Brauns | 1 |
Publication | Filing date | Title |
---|---|---|
CN108472317A | Modify immunocyte and application thereof |